Previous 10 | Next 10 |
The company was named to the list of BioSpace Movers and Shakers in July 2020 after veteran health plan executive Dennis A. Matheis joined its Board of Directors Global digital diabetes management market is projected to register CAGR of 17.8% by 2026 DarioHealth’s platform lauded...
A well-trained staff is key to the integrity and success of one’s clinical trial. During busy times, budgets are usually tight. As a result, training in clinical research fails to get the attention it needs. However, training in remote clinical research is affordable. It is an effective...
DarioHealth (NASDAQ: DRIO) is a pioneer in the global digital therapeutics market focused on delivering evidence-based interventions to people with chronic conditions. A recent article discussing DarioHealth reads, “Patient engagement in therapies leads to health success. Dario’...
Are you a facility owner considering the different options available in the Electronic Health Record System space? If that’s the case, you have probably heard or seen the term “SaaS" and “Hosted” to refer to different ways of licensing EHR products. These terms are ...
The European Medicines Agency (“EMA”) recently granted Orphan Medicinal Product designation in the EU to MIV-818 used for the treatment of patients with hepatocellular carcinoma (“HCC”), the primary type of liver cancer. This designation was granted after thorough a...
Dario’s popular (4.9 stars on the Apple App Store and 11,000 reviews) chronic condition management platform addresses a $72 billion annual U.S. market opportunity There are roughly 51,000 active users of the Dario platform, including its proprietary medical device, mobile applicati...
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced that the company has appointed veteran health plan executive Dennis A. Matheis to its Board of Directors, effective July 2, 2020. According to the update, Matheis brings to the Dario Board nearly 3...
NEW YORK , July 6, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company has appointed veteran health plan executive Dennis A. Matheis to its Board of Directors, effective July 2, 2020 . Mr. Mat...
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced that Omar Manejwala, M.D., Chief Medical Officer, will present at the virtual Going Digital: Behavioral Tech Summit. According to the update, DarioHealth is a sponsor of the event that brings toget...
NEW YORK , June 18, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of diabetes and other chronic conditions on Tuesday...
News, Short Squeeze, Breakout and More Instantly...
DarioHealth (NASDAQ: DRIO) , a leader in the global digital health market, is planning to release its financial results for the first quarter 2024, the period ended March 31, 2024. According to the announcement, the company will release the report on May 15, 2024, before the market opens. In addi...
DarioHealth to Report First Quarter 2024 Results on Wednesday, May 15th PR Newswire Company to host conference call and webcast at 8:30am ET NEW YORK , May 7, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the globa...
Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes PR Newswire Quasi-randomized study demonstrates the value of Dario's integrated approach to provide one solu...